Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
To examine the safety and immunogenicity of two formulation of liposomal adjuvant / delivery system (VaxiSomeTM=CCS-Cholesterol \[CCS/C\]), combined with commercial influenza vaccine in an elderly healthy population when given once intramuscularly (IM).
Epistemonikos ID: 9d8d0d68d6129f6a33a8b1f4828e18b1c92b195c
First added on: May 05, 2024